ESC 365 - Exhaled breath acetone as a biomarker of disease severity and exercise intolerance in heart failure

Open Access

Exhaled breath acetone as a biomarker of disease severity and exercise intolerance in heart failure

Session: Advances in mechanisms of heart failure

Topic: Pathophysiology

Speaker: Doctor N. De Biase (Pisa, IT)

Event: Heart Failure 2025

Congress Presentation

Add to my library

About the speaker

Doctor Nicolo' De Biase

University Hospital of Pisa, Pisa (Italy)

0 follower

6 more presentations in this session

Serum amyloid a1 reflects activation of interleukin 1b, 6, and 17 and is specifically upregulated in heart failure with a preserved ejection fraction

Speaker: Mr B. Van Essen (Groningen, NL)

Immune cell signature in non-ischemic heart failure indicates chronic activation and immunosenescence

Speaker: Mr L. Baumhove (Groningen, NL)

EDEM2 is a new therapeutic target for improving diabetes-induced cardiomyopathy by regulating DSG2

Speaker: Miss J. Zhang (Manchester, GB)

Inositol 1,4,5-trisphosphate receptors (ITP3Rs) ablation reduces the expression of chemokine ligands and pro-inflammatory interleukins

Speaker: Doctor U. Kansakar (Bronx, US)

The role of EDEM2 in the heart under metabolic stress

Speaker: Miss O. Fonseka (Manchester, GB)

Access the full session

Advances in mechanisms of heart failure

Speakers: Doctor N. De Biase, Mr B. Van Essen, Mr L. Baumhove, Miss J. Zhang, Doctor U. Kansakar...

About the event

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources